Healthcare

Best Performing Equity Today

Incannex Healthcare

17.39%

Healthcare Insights

Incannex mother and child

insight

Healthcare

Incannex Healthcare: Data opens path to treat anxiety

insight

Healthcare

February 2023 Edition of Edison Healthcare Insight

insight

Healthcare

Healthcare Week 2023

edison healthcare insight

insight

Healthcare

December 2022 edition of Edison Healthcare Insight

Analyst of the week

Soo Romanoff

Soo Romanoff

Managing Director - Head of Content, Healthcare

Read latest

Equities

OpGen (OPGN)

Latest price

USD0.46

0.04 (9.52)
As at 28/11/2023
Market capitalisation
USD4m
View equity
Laboratory Opgen

Update

Healthcare

OpGen — Cash concerns dampen active Q2

Laboratory Opgen

Flash note

Healthcare

OpGen — FIND collaboration advances to development

Flash note

Healthcare

OpGen — Feasibility milestone from FIND collaboration

Oryzon Genomics (ORY)

Latest price

EUR2.05

0.03 (1.49)
As at 28/11/2023
Market capitalisation
EUR118m
View equity

OSE Immunotherapeutics (OSE)

Latest price

EUR4.07

−0.23 (−5.35)
As at 28/11/2023
Market capitalisation
EUR92m
View equity

Paradigm Biopharma (PAR)

Latest price

AUD0.39

−0.01 (−1.28)
As at 28/11/2023
Market capitalisation
AUD141m
View equity

Pharnext (ALPHA)

Latest price

EUR0.10

0.03 (42.86)
As at 28/11/2023
Market capitalisation
EUR1m
View equity

Pixium Vision (PIX)

Latest price

EUR0.15

−0.04 (−21.05)
As at 28/11/2023
Market capitalisation
EUR1m
View equity

Recce Pharmaceuticals (RCE)

Latest price

AUD0.44

0.00 (0.00)
As at 28/11/2023
Market capitalisation
AUD93m
View equity

Renaissance BioScience (RENABIOTICKER)

Latest price

0.00 (0.00)
As at 28/11/2023
Market capitalisation
View equity

ReNeuron Group (RENE)

Latest price

GBP0.04

0.12 (2.91)
As at 28/11/2023
Market capitalisation
GBP2m
View equity

Respiri (RSH)

Latest price

AUD0.03

−0.01 (−15.63)
As at 28/11/2023
Market capitalisation
AUD31m
View equity

Sareum Holdings (SAR)

Latest price

GBP0.60

0.00 (0.00)
As at 28/11/2023
Market capitalisation
GBP44m
View equity

Sequana Medical (SEQUA)

Latest price

EUR2.46

−0.04 (−1.60)
As at 28/11/2023
Market capitalisation
EUR68m
View equity

Shield Therapeutics (STX)

Latest price

GBP0.06

−0.20 (−3.33)
As at 28/11/2023
Market capitalisation
GBP49m
View equity

SIGA Technologies (SIGA)

Latest price

USD5.33

−0.01 (−0.19)
As at 28/11/2023
Market capitalisation
USD368m
View equity

Ultimovacs (ULTI)

Latest price

NOK116.00

−3.80 (−3.17)
As at 28/11/2023
Market capitalisation
NOK3,902m
View equity

Curated by Edison

The Next Step for AI in Biology Is to Predict How Proteins Behave in the Body - Thumbnail image

singularityhub.com

The Next Step for AI in Biology Is to Predict How Proteins Behave in the Body

Healthcare

A new protein atlas can help turn static AI predictions of protein shapes into more fluid predictions of how proteins behave in the body.

Read article
The Cost of Sequencing a Human Genome - Thumbnail image

www.genome.gov

The Cost of Sequencing a Human Genome

Healthcare

Estimated cost of sequencing the human genome over time since the Human Genome Project.

Read article
J.P. Morgan Launches New Life Sciences Private Capital Team Targeting Investments in Innovative Healthcare Companies - Thumbnail image

www.prnewswire.com

J.P. Morgan Launches New Life Sciences Private Capital Team Targeting Investments in Innovative Healthcare Companies

Healthcare

/PRNewswire/ -- J.P. Morgan Asset Management today announced the launch of a new life sciences private equity team, Life Sciences Private Capital. The new team...

Read article
Leveraging nanotechnology to transform the disinfection industry - Thumbnail image

insights.omnia-health.com

Leveraging nanotechnology to transform the disinfection industry

Healthcare

Co-founders of Kismet Technologies, Christina Drake and Shari Costantini, discuss how NanoRad, one of their flagship products, uses targeted application to kill a wide range of bacteria and viruses.

Read article
2022 Healthcare Provider IT Report: Post-Pandemic Investment Priorities - Thumbnail image

www.bain.com

2022 Healthcare Provider IT Report: Post-Pandemic Investment Priorities

Healthcare

As healthcare providers enter a new period of disruption, their software investment priorities present opportunities for vendors and investors.

Read article

Thematics

thematic

Healthcare

Neuroscience comeback

thematic

Consumer

IPO apocalypse

thematic

Healthcare

Oncology ABCs (part two) – vaccines: niche no longer

thematic

TMT

ESG, moving beyond the box tick

thematic

Healthcare

Artificial intelligence in drug discovery

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free